Literature DB >> 17189219

Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation.

Seiji Madoiwa1, Shin Nunomiya, Tomoko Ono, Yuichi Shintani, Tsukasa Ohmori, Jun Mimuro, Yoichi Sakata.   

Abstract

Sepsis-induced disseminated intravascular coagulation (DIC) is a serious condition because it is closely linked to the development of multiple organ dysfunctions. We compared molecular fibrinolysis markers for 117 patients with sepsis-induced DIC and 1627 patients with nonseptic DIC. Levels of fibrinogen and fibrin degradation products and D-dimer were significantly lower in sepsis-induced DIC cases than in nonseptic DIC cases. In septic DIC cases, plasma plasminogen activator inhibitor 1 (PAI-1) levels were significantly higher than in nonseptic DIC cases. D-dimer levels were negatively correlated with plasma PAI-1 levels in septic DIC cases. Multiple Organ Dysfunction Scores were significantly higher in septic DIC patients with PAI-1 levels >90 ng/mL than in the group with PAI-1 levels <30 ng/mL. The Kaplan-Meier survival functions until 28 days after DIC diagnosis were significantly lower in the group with PAI-1 levels >90 ng/mL than in the other groups. In a multivariate analysis, plasma PAI-1 levels at DIC diagnosis were an independent risk factor for mortality in sepsis-induced DIC (hazard ratio, 1.012; P = .008). These data suggest that plasma PAI-1 plays an important role in sustaining DIC in septic DIC cases and contributes to multiple organ failure and decreased survival in such patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17189219     DOI: 10.1532/IJH97.05190

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  37 in total

1.  Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

Authors:  F B Taylor; C H Toh; W K Hoots; H Wada; M Levi
Journal:  Thromb Haemost       Date:  2001-11       Impact factor: 5.249

Review 2.  Disseminated intravascular coagulation.

Authors:  Sjoukje H Slofstra; C Arnold Spek; Hugo ten Cate
Journal:  Hematol J       Date:  2003

3.  Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock.

Authors:  P M Jansen; B Eisele; I W de Jong; A Chang; U Delvos; F B Taylor; C E Hack
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

Review 4.  Treating patients with severe sepsis.

Authors:  A P Wheeler; G R Bernard
Journal:  N Engl J Med       Date:  1999-01-21       Impact factor: 91.245

5.  Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons.

Authors:  K E Welty-Wolf; M S Carraway; D L Miller; T L Ortel; M Ezban; A J Ghio; S Idell; C A Piantadosi
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

6.  Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group.

Authors:  S M Opal; C J Fisher; J F Dhainaut; J L Vincent; R Brase; S F Lowry; J C Sadoff; G J Slotman; H Levy; R A Balk; M P Shelly; J P Pribble; J F LaBrecque; J Lookabaugh; H Donovan; H Dubin; R Baughman; J Norman; E DeMaria; K Matzel; E Abraham; M Seneff
Journal:  Crit Care Med       Date:  1997-07       Impact factor: 7.598

7.  Decreased tissue factor and tissue-plasminogen activator antigen in relapsed acute promyelocytic leukemia.

Authors:  T Nakasaki; H Wada; Y Mori; Y Okugawa; R Watanabe; M Nishikawa; E C Gabazza; M Masuya; S Kageyama; K Kumeda; H Kato; H Shiku
Journal:  Am J Hematol       Date:  2000-07       Impact factor: 10.047

8.  The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group.

Authors:  G R Bernard; A P Wheeler; J A Russell; R Schein; W R Summer; K P Steinberg; W J Fulkerson; P E Wright; B W Christman; W D Dupont; S B Higgins; B B Swindell
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

Review 9.  Coagulation disorders in septic shock.

Authors:  L G Thijs; J P de Boer; M C de Groot; C E Hack
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

10.  Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome.

Authors:  S Gando; Y Nakanishi; I Tedo
Journal:  Crit Care Med       Date:  1995-11       Impact factor: 7.598

View more
  44 in total

1.  Bacterial lipoprotein TLR2 agonists broadly modulate endothelial function and coagulation pathways in vitro and in vivo.

Authors:  Hae-Sook Shin; Fengyun Xu; Aranya Bagchi; Elizabeth Herrup; Arun Prakash; Catherine Valentine; Hrishikesh Kulkarni; Kevin Wilhelmsen; Shaw Warren; Judith Hellman
Journal:  J Immunol       Date:  2010-12-17       Impact factor: 5.422

Review 2.  Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.

Authors:  Toshiaki Iba; Jecko Thachil
Journal:  Int J Hematol       Date:  2015-11-20       Impact factor: 2.490

3.  The Japanese guidelines for the management of sepsis.

Authors:  Shigeto Oda; Mayuki Aibiki; Toshiaki Ikeda; Hitoshi Imaizumi; Shigeatsu Endo; Ryoichi Ochiai; Joji Kotani; Nobuaki Shime; Osamu Nishida; Takayuki Noguchi; Naoyuki Matsuda; Hiroyuki Hirasawa
Journal:  J Intensive Care       Date:  2014-10-28

4.  Thrombin Provokes Degranulation of Platelet α-Granules Leading to the Release of Active Plasminogen Activator Inhibitor-1 (PAI-1).

Authors:  Benjamin R Huebner; Ernest E Moore; Hunter B Moore; Gregory R Stettler; Geoffrey R Nunns; Peter Lawson; Angela Sauaia; Marguerite Kelher; Anirban Banerjee; Christopher C Silliman
Journal:  Shock       Date:  2018-12       Impact factor: 3.454

5.  Effects of aliskiren on the fibrinolytic system in patients with coronary artery disease receiving angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor blocker.

Authors:  Ken Ishibashi; Satoshi Kurisu; Yasuko Kato; Naoya Mitsuba; Yoshihiro Dohi; Kenji Nishioka; Yasuki Kihara
Journal:  Heart Vessels       Date:  2011-11-02       Impact factor: 2.037

Review 6.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

7.  4G/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic study.

Authors:  Krisztina Madách; István Aladzsity; Agnes Szilágyi; George Fust; János Gál; István Pénzes; Zoltán Prohászka
Journal:  Crit Care       Date:  2010-04-29       Impact factor: 9.097

8.  Myeloperoxidase instigates proinflammatory responses in a cecal ligation and puncture rat model of sepsis.

Authors:  Hong Yu; Yajun Liu; Meifang Wang; Ricardo J Restrepo; Derek Wang; Theodore J Kalogeris; William L Neumann; David A Ford; Ronald J Korthuis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-08-07       Impact factor: 4.733

9.  SuPAR and PAI-1 in critically ill, mechanically ventilated patients.

Authors:  Ville Jalkanen; Runkuan Yang; Rita Linko; Heini Huhtala; Marjatta Okkonen; Tero Varpula; Ville Pettilä; Jyrki Tenhunen
Journal:  Intensive Care Med       Date:  2012-10-26       Impact factor: 17.440

Review 10.  Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury.

Authors:  Trung C Nguyen; Miguel A Cruz; Joseph A Carcillo
Journal:  Crit Care Clin       Date:  2015-08-07       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.